Embryo News and Research

RSS

Most Americans skeptical about gene editing

A new survey from Pew Research Center has found that nearly half of the surveyed Americans believe that in the coming 50 years, nearly all genetic birth defects could be eliminated due to advances in gene editing.

26 Jul 2018

Small RNA in sperm shown to be essential for embryonic development

New research has shown that small RNA in sperm is essential for embryo implantation and embryonic development. The findings will be used to optimize IVF.

26 Jul 2018

New study may advance clinical management of infertile couples

A research team have identified the mechanism by which the fertilized egg balances out chromosomes inherited from the mother and the father.

25 Jul 2018

Research deepens understanding of mechanism behind organ morphogenesis

Many organs arise from simple sheets and tubes of cells. During development, these sheets bend and deform into the more complex final shape of the organ.

13 Jul 2018

Fluorescent zebrafish genes provide clues about neuroblastoma

Researchers have created transgenic zebrafish that could help them understand how neuroblastoma, a common pediatric cancer, develops.

10 Jul 2018

Fluorescent fish could help find origins of neuroblastoma

A new type of zebrafish that produces fluorescent tags in migratory embryonic nerve precursor cells could help a Rice University neurobiologist and cancer researcher find the origins of the third-most common pediatric cancer in the U.S.

10 Jul 2018

Researchers find new way to convert skin cells into pluripotent stem cells

Our bodies consist of many different kinds of cells, each with their own role. The Japanese scientist Shinya Yamanaka had made earlier the discovery, earning the Nobel Prize in 2012, that cells from adult skin can be converted to cells typical of early embryos, so-called induced pluripotent stem cells.

6 Jul 2018

Scientists develop novel method of producing pluripotent stem cells

Scientists have developed a modified CRISPR tool that can stimulate the de-differentiation of somatic cells into induced pluripotent stem cells,

6 Jul 2018

8 million babies born through IVF says study

Louise Brown was the first “test-tube” baby who was born in 1978. It has been forty years since then and an international committee looked at the progress of assisted reproduction through these years. The report states that more than 8 million babies were born using IVF technology during this time.

4 Jul 2018

Preventive treatment for recurrent pregnancy loss proved ineffective in large study

An immune response to pregnancy (in which the uterus rejects the embryo or fetus) is said to explain a large number of otherwise "unexplained" miscarriages.

3 Jul 2018

Over 8 million babies born from IVF since the birth of world's first test-tube baby

Forty years after the birth of Louise Brown, the world's first test-tube baby, an international committee monitoring progress in assisted reproduction reports today that the global total of babies born as a result of IVF and other advanced fertility treatments is "more than 8 million"

3 Jul 2018

Lack of stable partner is major reason for women freezing their eggs, shows study

Contrary to common suggestion, women are opting to freeze their eggs not to pursue education or careers but for reasons "mostly revolving around women's lack of stable partnerships with men committed to marriage and parenting".

2 Jul 2018

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that Japan's Pharmaceuticals and Medical Devices Agency has approved LYNPARZA tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 -negative breast cancer who have received prior chemotherapy.

2 Jul 2018

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

Ferring Pharmaceuticals announced today a new analysis of data from the Phase 3 ESTHER-1 trial showing that natural variations in anti-Müllerian hormone levels during and between a woman's menstrual cycle have no clinically relevant impact on ovarian response when using AMH to dose Rekovelle for ovarian stimulation.

2 Jul 2018